Company · Ownership research
Aktis Oncology, Inc. AKTS
Q2 2026113 holders
Jun 30, 2026 · Current
Q1 202669 holders
Mar 31, 2026
Q4 20250 holders
Dec 31, 2025
Q3 20250 holders
Sep 30, 2025
Q2 20250 holders
Jun 30, 2025
Q1 20250 holders
Mar 31, 2025
Q4 20240 holders
Dec 31, 2024
Q3 20240 holders
Sep 30, 2024
Q2 20240 holders
Jun 30, 2024
Q1 20240 holders
Mar 31, 2024
Q4 20230 holders
Dec 31, 2023
CIK 0002035832 · CUSIP 01021M104
Q3 2023 is outside the free window
Loading…